| |
| |
|
| Insider
Information: |
Bohen Sean |
| Relationship: |
|
| City: |
San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
144,925 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
144,925 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Olema Pharmaceuticals, Inc. |
OLMA |
|
2023-11-22 |
144,925 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| OLMA |
Olema Pharmaceuticals, In... |
PRESIDENT AND CEO |
• • – |
2023-11-22 |
4 |
S |
$13.90 |
$388,255 |
D/D |
(27,932) |
144,925 |
0 |
- |
|
| OLMA |
Olema Pharmaceuticals, In... |
PRESIDENT AND CEO |
• • – |
2023-11-21 |
4 |
S |
$14.84 |
$435,879 |
D/D |
(29,293) |
172,857 |
0 |
- |
|
| OLMA |
Olema Pharmaceuticals, In... |
PRESIDENT AND CEO |
• • – |
2023-11-20 |
4 |
A |
$0.00 |
$0 |
D/D |
110,250 |
202,150 |
0 |
- |
|
| OLMA |
Olema Pharmaceuticals, In... |
PRESIDENT AND CEO |
• • – |
2022-09-21 |
4/A |
B |
$0.00 |
$0 |
D/D |
20,000 |
74,279 |
0.01 |
- |
|
| OLMA |
Olema Pharmaceuticals, In... |
PRESIDENT AND CEO |
• • – |
2022-09-21 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
74,279 |
0 |
- |
|
| OLMA |
Olema Pharmaceuticals, In... |
PRESIDENT AND CEO |
• • – |
2021-10-14 |
4 |
AS |
$30.42 |
$152,363 |
D/D |
(5,000) |
52,514 |
0 |
- |
|
| OLMA |
Olema Pharmaceuticals, In... |
PRESIDENT AND CEO |
• • – |
2021-10-14 |
4 |
OE |
$4.82 |
$24,120 |
D/D |
5,000 |
57,514 |
0 |
- |
|
| OLMA |
Olema Pharmaceuticals, In... |
PRESIDENT AND CEO |
• • – |
2021-09-27 |
4 |
AS |
$30.07 |
$32,626 |
D/D |
(1,085) |
52,514 |
0 |
- |
|
| OLMA |
Olema Pharmaceuticals, In... |
PRESIDENT AND CEO |
• • – |
2021-09-27 |
4 |
OE |
$4.82 |
$5,234 |
D/D |
1,085 |
53,599 |
0 |
- |
|
| OLMA |
Olema Pharmaceuticals, In... |
PRESIDENT AND CEO |
• • – |
2021-09-08 |
4 |
AS |
$30.00 |
$78,930 |
D/D |
(2,631) |
52,514 |
0 |
- |
|
| OLMA |
Olema Pharmaceuticals, In... |
PRESIDENT AND CEO |
• • – |
2021-09-08 |
4 |
OE |
$4.82 |
$12,692 |
D/D |
2,631 |
56,905 |
0 |
- |
|
| OLMA |
Olema Pharmaceuticals, In... |
PRESIDENT AND CEO |
• • – |
2021-09-07 |
4 |
AS |
$30.08 |
$12,423 |
D/D |
(413) |
54,274 |
0 |
- |
|
| OLMA |
Olema Pharmaceuticals, In... |
PRESIDENT AND CEO |
• • – |
2021-09-07 |
4 |
OE |
$4.82 |
$1,992 |
D/D |
413 |
54,687 |
0 |
- |
|
| OLMA |
Olema Pharmaceuticals, In... |
PRESIDENT AND CEO |
• • – |
2021-09-01 |
4 |
AS |
$30.05 |
$26,174 |
D/D |
(871) |
54,274 |
0 |
- |
|
| OLMA |
Olema Pharmaceuticals, In... |
PRESIDENT AND CEO |
• • – |
2021-09-01 |
4 |
OE |
$4.82 |
$4,202 |
D/D |
871 |
55,145 |
0 |
- |
|
| OLMA |
Olema Pharmaceuticals, In... |
President and CEOOfficer |
• • – |
2020-11-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
51,649 |
|
- |
|
| OLMA |
Olema Pharmaceuticals, In... |
President and CEO |
• • – |
2020-09-23 |
4 |
OE |
$4.82 |
$249,155 |
D/D |
51,649 |
51,649 |
0 |
- |
|
17 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
